St Vincent's Hospital, Sydney
Clinical trials sponsored by St Vincent's Hospital, Sydney, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Hormone boost plus chemo aims to shrink hard-to-treat prostate cancer Results expected Sep 2026 (estimated)
-
New drug shows promise in shrinking eye cancer before surgery
Disease control CompletedThis phase 2 trial tested the drug darovasertib in 15 people with high-risk uveal melanoma (a rare eye cancer) who were scheduled for eye removal surgery. Participants took the drug for up to 4 weeks before surgery, and some continued for 6 months afterward. The main goals were t…
Phase 2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a new PET tracer spot breast cancer spread better than standard scans?
Diagnosis CompletedThis trial is testing whether a new PET imaging agent called NeoB can more accurately detect the spread of a certain type of breast cancer (ER/PR positive, HER2 negative) compared to conventional scans like CT, bone scans, and FDG PET/CT. The study will enroll 20 women with metas…
Phase 2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
Can a new tracer spot prostate cancer return better than the standard scan?
Diagnosis CompletedThis trial tests whether a new PET/CT tracer, 64Cu-SAR-bisPSMA, can find more sites of prostate cancer recurrence than the standard 68Ga PSMA-11 scan in men whose PSA rises after prostate removal. Fifty men will receive both scans, and researchers will compare how many lesions ea…
Phase 2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Tiny trial aims to shed light on PSMA scans in hard-to-treat prostate cancer
Knowledge-focused CompletedThis study tested whether taking dasatinib alone or with darolutamide for 14 days can increase PSMA levels on PET scans in men with metastatic prostate cancer. Only 4 men participated, all with low PSMA uptake on their initial scan. The goal was to learn more about how PSMA expre…
Phase 2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC